Bicalutamide and Third-Generation Aromatase Inhibitors in Testotoxicosis
Authors:
- 1 September 2010
- journal article
- case report
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 126 (3) , e728-e733
Abstract
Testotoxicosis, a form of gonadotropin-independent precocious puberty, results from an activating mutation of the luteinizing hormone receptor expressed in testicular Leydig cells. Affected males experience early testosterone secretion, virilization, advancing bone age, and resultant short stature. Recently, the use of combination therapy with a potent antiandrogen agent (bicalutamide) and a third-generation aromatase inhibitor (anastrozole or letrozole) was reported to yield encouraging short-term results. We present here the results of longer-term treatment (4.5 and 5 years) with this combination therapy in 2 boys who demonstrated that it is well tolerated, slows bone-age advancement in the face of continued linear growth, and prevents progression of virilization.Keywords
This publication has 40 references indexed in Scilit:
- Estrogen Negative Feedback on Gonadotropin Secretion: Evidence for a Direct Pituitary Effect in WomenThe Journal of Clinical Endocrinology & Metabolism, 2010
- Impact of Aromatase Inhibitor Therapy on Bone Turnover, Cortical Bone Growth and Vertebral Morphology in Pre- and Peripubertal Boys with Idiopathic Short StatureHormone Research in Paediatrics, 2009
- LH receptor gene mutations and polymorphisms: An overviewMolecular and Cellular Endocrinology, 2007
- Treatment of familial male-limited precocious puberty with bicalutamide and anastrozoleThe Journal of Pediatrics, 2006
- Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis).Journal of Medical Genetics, 1995
- Why testicles are coolNature, 1994
- Treatment of Familial Male Precocious Puberty with Spironolactone and TestolactoneNew England Journal of Medicine, 1989
- Ketoconazole in the Management of Precocious Puberty Not Responsive to LHRH-Analogue TherapyNew England Journal of Medicine, 1985
- Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: Familial testotoxicosisThe Journal of Pediatrics, 1985
- Male-Limited Familial Precocious Puberty in Three GenerationsNew England Journal of Medicine, 1984